IMAC Holdings Inc. Common Stock BACK · Stock Open IMAC Holdings Inc. Common Stock in new tab
IMAC Holdings Inc. Common Stock Analysis (BACK)
Is IMAC Holdings Inc. Common Stock a good investment? IMAC Holdings Inc. Common Stock (BACK) is currently trading at 0.000600 USD.
Earnings Schedule: IMAC Holdings Inc. Common Stock is expected to release its next earnings report on Nov. 17, 2026. The market consensus estimate for Forward EPS is -3.48.
Investor FAQ
Does IMAC Holdings Inc. Common Stock pay a dividend?
No, it does not currently pay a dividend.
What asset class is IMAC Holdings Inc. Common Stock?
IMAC Holdings Inc. Common Stock is classified as a Stock. You can compare it against its peer in the "Related Symbols" list.
When is the next earnings date?
The next earnings date is projected to be Nov. 17, 2026. The company currently has a trailing EPS of -2.98.
Company Profile
IMAC Holdings, Inc., through its subsidiary, Ignite Proteomics LLC, provides proteomic product and precision medicine services based on activated protein analysis for the treatment of cancer in the United States. The company offers a reverse phase protein array (RPPA) platform, which can quantify protein signaling to support oncology clinical treatment decisions and biopharmaceutical drug development. IMAC Holdings, Inc. was founded in 2000 and is based in Franklin, Tennessee.
| Split Date | Split Ratio to 1 |
|---|---|
| Sept. 8, 2023 | 0.03 |
Community Discussion